Last updated on January 2020

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy

Find a site near you

Start Over

Lahey Hospital and Medical Center /ID# 214725

Burlington, MA United States
  Connect »